Using New Genetic Technology to Diagnose Neurodevelopmental Disorders
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 119
- 试验地点
- 1
- 主要终点
- Genetic abnormality identified by microarray or Next Generation Sequencing
研究概览
简要总结
Learning disability affects 3% of the population. Severe types of learning disability are more likely to have an underlying genetic cause but diagnosis is difficult because many different genetic abnormalities may be involved. Obtaining a diagnosis is important so that patients can be managed appropriately and their families can be given accurate information.
We aim to use new types of genetic testing which will make it possible to screen for several different genetic abnormalities which cause learning disability at the same time, so improving the accuracy and speed of diagnosis in the group of patients with severe learning disability. We will focus particularly on patients where seizures and behavioural problems are also present.This will enable more patients to be diagnosed accurately, reduce the number of hospital appointments needed and ultimately be more cost- effective.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Individuals with severe learning disability associated with either seizures, movement or behaviour problems who had previously undergone routine investigation but where no cause had been identified for their problems
排除标准
- •Individuals with SLD where the cause is already known
- •Individuals where informed consent cannot be obtained for participation
结局指标
主要结局
Genetic abnormality identified by microarray or Next Generation Sequencing
时间窗: up to 6 months following consent
Abnormalities identified upon results of testing, the normal timeframe for this is up to 6 months after collecting blood sample.
次要结局
- Cost effectiveness vs normal care(By the end of the study (December 2014))
